IRWD FY 2010 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$591M

FY 2010 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$44M+21.5% YoY

Gross Profit

$44M100.0% margin

Operating Income

-$61M-138.6% margin

Net Income

-$53M-120.8% margin

EPS (Diluted)

$-0.59

Cash Flow

Operating Cash Flow

-$68M

Free Cash Flow

-$85M

Stock-Based Comp.

$7M

Balance Sheet

Total Assets

$301M

Total Liabilities

$142M

Stockholders' Equity

$160M

Cash & Equivalents

$44M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$44M	$36M	+21.5%
Gross Profit	$44M	$36M	+21.5%
Operating Income	-$61M	-$73M	+16.5%
Net Income	-$53M	-$71M	+25.6%